Daily as of 3 Nov 16:00 ET
- Price
- above both $6.04 vs 50 $4.33 / 200 $4.61
- Projection
- 🟨Golden cross projected in 5 bars
- Test
- No active test
- Last cross
- 💀Death cross 18 Feb 2026 · projected 28 bars out
MYGN | Myriad GeneticsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$6.04
+$0.19 (+3.25%)
Myriad Genetics (MYGN) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.
Right now the daily is the chart to watch. The 50 SMA has sat below the 200 since Feb 2026, but the two have been closing on each other and a golden cross is projected within 10 bars. On both the daily and the 4-hour, price sits above the 50 and the 200; on the weekly it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- between the two $6.35 vs 50 $4.94 / 200 $13.93
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross week of 12 Sep 2022 · projected 27 bars out
4-hour as of 3 Nov 16:00 ET
- Price
- above both $6.04 vs 50 $5.04 / 200 $4.50
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 22 Oct 2026 · projected 24 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Oct 2026 | 🟨Golden | 4-hour | 24 bars out | Not tested |
| 14 Aug 2026 | 💀Death | 4-hour | 21 bars out | Not tested |
| 1 Jul 2026 | 🟨Golden | 4-hour | 17 bars out | Not tested |
| 18 Feb 2026 | 💀Death steep | daily | 28 bars out | Not tested |
| 30 Dec 2025 | 💀Death | 4-hour | 15 bars out | Not tested |
About MYGN
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$6.7M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall